NurAID 2 MLC 901, 180 capsules, Beacons Pharmaceuticals

NurAID 2 MLC 901, 180 capsules, Beacons Pharmaceuticals

1. NurAiD II is a treatment based on natural plant extracts that allows stroke patients to enhance and accelerate recovery. It increases the patients' chances of regaining their autonomy and regaining their motor and sensory functions.
2. NurAiD II is a food supplement that activates recovery. Clinical studies suggest the use of NurAiD II up to 6 months after the occurrence of a stroke. The pharmacological data suggest the start of treatment with NurAiD II as soon as possible after the occurrence of an ischemic stroke and after the stabilization of the patient following a hemorrhagic stroke.
3. NurAiD II acts by stimulating the secretion of BNDF (Brain-Derived Neurotrophic Factor) which acts on some neurons from the central and peripheral nervous system, helping the survival of existing nerve cells, while encouraging the growth and differentiation of new synapses and new neurons. At the same time, NurAiD II stimulates the proliferation of neuronal precursors and their maturation.
4. According to studies, there are 2.4 times more chances of recovering autonomy, a 70% reduction in stroke-related motor deficits and an increase in the recovery of vision and language.
5. NurAiD II is a natural treatment composed of 9 natural ingredients of plant origin: astragalus root, sage root, peony root, leustean rhizome, Chinese angelica sinensis root, saffron, polygala root, sweet grass rhizome and peach .
6. Until now, there are no contraindications for this treatment, nor are there any clinical studies on the potential effects on children, pregnant or breastfeeding women. A few rare cases of transient and moderate headache, nausea and vomiting have been reported. Fortunately, NurAiD II does not affect renal, hepatic, hematological or cardiac functions and no drug interactions have been discovered.

Presentation:
180 capsules - 91 g